AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
H. Lundbeck's Cipralex drug approved in several European countries.(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
The Danish pharmaceutical company H. Lundbeck A/S reports that ten European countries have now approved its Cipralex drug for the treatment of depression and anxiety.
The countries are Belgium, Denmark, Britain, France, Ireland, Iceland, Luxembourg, Norway, Sweden and Austria. In addition, Cipralex has been approved as a treatment for depression in Switzerland and Lithuania. The launch of Cipralex, which is a successor to Lundbeck's top-selling drug Cipramil, in all those countries will take place immediately after the marketing …
-
- H. Lundbeck's depression drug approved in Switzerland.(Brief Article)(Product...
-
Newspaper article from: M2 Europharma
January 3, 2002
700+ words
-
- Sweden approves Lundbeck's new depression and panic disorder drug.(H....
-
Newspaper article from: M2 Europharma
December 10, 2001
700+ words
